SIRT2, ERK and Nrf2 Mediate NAD(+) Treatment-Induced Increase in the Antioxidant Capacity of PC12 Cells Under Basal Conditions

por Zhang, Jie, Hong, Yunyi, Cao, Wei, Yin, Shankai, Shi, Haibo, Ying, Weihai
Publicado 2019

Nicotinamide mononucleotide improves energy activity and survival rate in an in vitro model of Parkinson’s disease

por LU, LEI, TANG, LE, WEI, WENSHI, HONG, YUNYI, CHEN, HEYU, YING, WEIHAI, CHEN, SHENGDI
Publicado 2014